CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
EXPLORER PET/CTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04812080
NCT04812080N/ACompleted

EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations

University of California, Davis·interventional·Posted Mar 23, 2021·Updated Mar 11, 2026

In Brief

A clinical study evaluating EXPLORER PET/CT for Healthy Volunteers From Racial/Ethnic Minority Populations. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The objective of this pilot study is to collect preliminary data using total body scans on a new, first of its kind, FDA 510k-cleared positron emission tomography/computed tomography (PET/CT) scanner, called EXPLORER. The study will aim to recruit healthy individuals from racial/ethnic minority populations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 23, 2021
Enrollment StartAug 18, 2021
Primary CompletionNov 8, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.3 years ago

Interventions

EXPLORER PET/CTdevice

FDG PET Scans on the total body EXPLORER PET/CT scanner